# Dare Bioscience, Inc.: funding, H-1B, 10-K (November 2026)

Registers read on November 19, 2026.

Dare Bioscience, Inc. (California) appears in 4 public registers SpecStream reads: 13 Form D filings, 1 certified H-1B or PERM case, 5 SEC annual and quarterly reports and 5 NIH and NSF awards; the newest record is dated August 20, 2026, and the registers were read on November 19, 2026.

SpecStream is the live web data engine for teams and agents. This page joins the public registers SpecStream already reads for one company.

- Registers: 4
- Newest record: August 20, 2026
- State: California

## Form D filings (SEC)

13 Form D filings, newest August 20, 2026.

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [Form D](https://specstream.ai/data/form-d/company/dare-bioscience-inc-1401914) | August 20, 2026 | $12.4 million sold of $12.4 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1401914/000149315226039295/0001493152-26-039295-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/dare-bioscience-inc-1401914) | November 22, 2024 | $0 sold of $15 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1401914/000149315224047445/0001493152-24-047445-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/dare-bioscience-inc-1401914) | December 26, 2023 | $1.7 million sold of $4.2 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1401914/000149315223046131/0001493152-23-046131-index.htm) |
| [Form D amendment](https://specstream.ai/data/form-d/company/dare-bioscience-inc-1401914) | September 7, 2021 | $3.5 million sold of $3.5 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1401914/000140191421000119/0001401914-21-000119-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/dare-bioscience-inc-1401914) | December 6, 2019 | $2.4 million sold of $2.4 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1401914/000140191419000103/0001401914-19-000103-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/dare-bioscience-inc-1401914) | July 28, 2017 | $20.7 million sold of $20.7 million offered; Biotechnology | [sec.gov](https://www.sec.gov/Archives/edgar/data/1401914/000140191417000003/0001401914-17-000003-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/dare-bioscience-inc-1401914) | October 17, 2016 | $1 sold of $1 offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1401914/000140191416000005/0001401914-16-000005-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/dare-bioscience-inc-1401914) | December 14, 2012 | $13 million sold of $13 million offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1401914/000140191412000001/0001401914-12-000001-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/dare-bioscience-inc-1401914) | December 15, 2011 | $15 million sold of $15 million offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1401914/000140191411000002/0001401914-11-000002-index.htm) |
| [Form D](https://specstream.ai/data/form-d/company/dare-bioscience-inc-1401914) | November 19, 2010 | $16.5 million sold of $24 million offered; Pharmaceuticals | [sec.gov](https://www.sec.gov/Archives/edgar/data/1401914/000140191410000003/0001401914-10-000003-index.htm) |

- [Dare Bioscience, Inc.](https://specstream.ai/data/form-d/company/dare-bioscience-inc-1401914)
- [SEC EDGAR filings](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1401914&type=D)

## H-1B and PERM certifications (Department of Labor)

1 certified H-1B or PERM case, newest October 4, 2024.

- EIN: 20-4139823

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [Senior Accountant](https://specstream.ai/data/hiring/employer/dare-bioscience-inc-204139823) | October 4, 2024 | H-1B, 1 case, $98.6 thousand offered | [dol.gov](https://www.dol.gov/sites/dolgov/files/ETA/oflc/pdfs/LCA_Disclosure_Data_FY2025_Q1.xlsx) |

- [Dare Bioscience, Inc.](https://specstream.ai/data/hiring/employer/dare-bioscience-inc-204139823)

## Public company financials (SEC)

5 SEC annual and quarterly reports, newest March 26, 2026.

- SEC central index key (CIK): 1401914
- Industry: SIC 2834, Pharmaceutical preparations
- Filer category: Non-accelerated filer

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [10-K filed March 26, 2026](https://specstream.ai/data/public-companies/company/1401914-dare-bioscience-inc) | March 26, 2026 | Revenue $1 million | [sec.gov](https://www.sec.gov/Archives/edgar/data/1401914/000140191426000004/0001401914-26-000004-index.htm) |

- [Dare Bioscience, Inc.](https://specstream.ai/data/public-companies/company/1401914-dare-bioscience-inc)

## NIH and NSF research awards

5 NIH and NSF awards, newest December 17, 2024.

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [NIH](https://specstream.ai/data/research-funding/organization/dare-bioscience-inc-uc4eflzhanh4) | December 17, 2024 | A first-in-class product for the clearance of high-risk human papillomaviruses; $1 million | [reporter.nih.gov](https://reporter.nih.gov/project-details/11064135) |
| [NIH](https://specstream.ai/data/research-funding/organization/dare-bioscience-inc-uc4eflzhanh4) | December 12, 2023 | A novel intravaginal ring technology featuring the sustained release of natural progesterone for the prevention of preterm birth in at-risk | [reporter.nih.gov](https://reporter.nih.gov/project-details/11000385) |
| [NIH](https://specstream.ai/data/research-funding/organization/dare-bioscience-inc-uc4eflzhanh4) | August 1, 2023 | Therapeutic targeting of FKBP51 for the prevention of stress-induced preterm birth; $385 thousand | [reporter.nih.gov](https://reporter.nih.gov/project-details/10758367) |
| [NIH](https://specstream.ai/data/research-funding/organization/dare-bioscience-inc-uc4eflzhanh4) | April 1, 2022 | Defining end-user preferences among US women to optimize the design of a long-acting injectable hormonal contraceptive; $249.3 thousand | [reporter.nih.gov](https://reporter.nih.gov/project-details/10459006) |
| [NIH](https://specstream.ai/data/research-funding/organization/dare-bioscience-inc-uc4eflzhanh4) | September 21, 2021 | Subcutaneous insertion and removal of a user-controlled, long-acting, and reversible contraceptive device; $309.6 thousand | [reporter.nih.gov](https://reporter.nih.gov/project-details/10378828) |

- [Dare Bioscience, Inc.](https://specstream.ai/data/research-funding/organization/dare-bioscience-inc-uc4eflzhanh4)

## How these records were matched

Records are joined when they carry the same SEC CIK, EIN or UEI, or when their legal names match word for word, legal form aside, at an address in the same state (California), and no register gives a second identifier, a second headquarters or a second filer of that name. Each record links to its own page and to the agency that published it.

Source: the registers named in each section. Public records of US federal and state agencies.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in California

- [Pharmaceutical companies in California, United States](https://specstream.ai/data/businesses/pharmaceutical-companies/california-united-states)
- [3D printing companies in California, United States](https://specstream.ai/data/businesses/3d-printing-companies/california-united-states)
- [Cabinet makers in California, United States](https://specstream.ai/data/businesses/cabinet-makers/california-united-states)
- [Electronic equipment suppliers in California, United States](https://specstream.ai/data/businesses/electronic-equipment-suppliers/california-united-states)
- [HVAC contractors in California, United States](https://specstream.ai/data/businesses/hvac-contractors/california-united-states)
- [Nepalese restaurants in California, United States](https://specstream.ai/data/businesses/nepalese-restaurants/california-united-states)
